Caplin Point Laboratories Q3 Results
- BSE: 524742
- NSE: CAPLIPOINT
- ISIN: INE475E01026
- Sector: Biotechnology & Drugs
BSE
2,195.00
-89.65 (-3.92%)
-89.65 (-3.92%)Volume4.71 K
Updated: Fri 23 May, 2025 | 15:29:36
NSE
2,192.80-95.70 (-4.18%)
-95.70 (-4.18%)Volume1.06 L
Updated: Fri 23 May, 2025 | 15:52:31
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Caplin Point Laboratories Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 492.96 | 483.10 | 2.04% | 435.50 | 13.19% |
| Selling/ General/ Admin Expenses Total | 46.77 | 44.29 | 5.60% | 36.67 | 27.54% |
| Depreciation/ Amortization | 16.20 | 16.76 | -3.34% | 13.90 | 16.55% |
| Other Operating Expenses Total | 88.55 | 85.23 | 3.90% | 66.44 | 33.28% |
| Total Operating Expense | 346.87 | 335.10 | 3.51% | 307.12 | 12.94% |
| Operating Income | 146.09 | 148.00 | -1.29% | 128.38 | 13.79% |
| Net Income Before Taxes | 177.26 | 168.46 | 5.22% | 145.41 | 21.90% |
| Net Income | 138.96 | 130.80 | 6.24% | 117.20 | 18.57% |
| Diluted Normalized EPS | 18.19 | 17.12 | 6.25% | 15.39 | 18.19% |